SCHEMBL19082365

SCHEMBL19082365

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5c6sc7ccccc7c6cc6c5sc5ccc7ccccc7c56)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.37
NQO1 P15559 1/20 0.37
ALOX5 P09917 1/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
GPR3 P46089 1/20 0.33
PARP14 Q460N5 1/20 0.32
PTPN1 P18031 1/20 0.32
TNKS O95271 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
DNMT1 P26358 1/20 0.31
ANPEP P15144 1/20 0.31
SOS1 Q07889 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
RAB9A P51151 1/20 0.31
MAP3K9 P80192 2/20 0.31
MAP3K11 Q16584 2/20 0.31
DHFR P00374 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945095 0.91 ALOX5 (0.42) NQO2NQO1ALOX5MAPTL3MBTL1
SCHEMBL19082276 0.90 ALOX5 (0.36) NQO2NQO1ALOX5MAPTL3MBTL1
SCHEMBL19082371 0.88 NQO1 (0.36) NQO2NQO1ALOX5MAPTGPR3
SCHEMBL19082193 0.86 TNKS (0.37) NQO2NQO1ALOX5MAPTL3MBTL1
SCHEMBL19082116 0.85 NQO1 (0.36) NQO2NQO1ALOX5MAPTGPR3
SCHEMBL19082370 0.85 NQO1 (0.36) NQO2NQO1ALOX5MAPTL3MBTL1
SCHEMBL17945668 0.85 ALOX5 (0.42) NQO2NQO1ALOX5MAPTL3MBTL1
SCHEMBL19082121 0.85 NQO2 (0.37) NQO2NQO1ALOX5MAPTPTPN1
SCHEMBL17943983 0.84 NQO2 (0.36) NQO2NQO1ALOX5MAPTPARP14
SCHEMBL19077428 0.84 ALOX5 (0.39) NQO2NQO1ALOX5MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885ALOX5 1939/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885ALOX5 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.